| |
 |
|
Class Information
Number: 424/184.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.)
Description: Subject matter involving an antigen, an epitope, or another immunospecific immunoeffector, such as an immunospecific vaccine, an immunospecific stimulator of cell-mediated immunity, an immunospecific tolerogen, or an immunospecific immunosuppressor.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 424/275.1 |
Allergen or component thereof (e.g., ragweed pollen, etc.) |
194 |
| 424/185.1 |
Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same |
1,792 |
| 424/234.1 |
Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) |
1,045 |
| 424/277.1 |
Cancer cell or component thereof |
384 |
| 424/203.1 |
Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) |
209 |
| 424/202.1 |
Combination of antigens from multiple viral species (e.g., multivalent viral vaccine, etc.) |
203 |
| 424/201.1 |
Combination of viral and bacterial antigens (e.g., multivalent viral and bacterial vaccine, etc.) |
134 |
| 424/193.1 |
Conjugate or complex |
846 |
| 424/274.1 |
Fungus, except allergen, or component thereof or substance produced by said fungus (e.g., trichophyton, etc.) |
96 |
| 424/192.1 |
Fusion protein or fusion polypeptide (i.e., expression product of gene fusion) |
968 |
| 424/198.1 |
Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof |
468 |
| 424/265.1 |
Parasitic organism or component thereof or substance produced by said parasitic organism (e.g., schistosoma, dirofilaria, trichinella, fasciola, ancylostoma, ascaris, etc.) |
250 |
| 424/200.1 |
Recombinant or stably-transformed bacterium encoding one or more heterologous proteins or fragments thereof |
245 |
| 424/199.1 |
Recombinant virus encoding one or more heterologous proteins or fragments thereof |
585 |
| 424/204.1 |
Virus or component thereof |
999 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7163682 |
Glucan binding protein and glucosyltransferase immunogens |
Jan. 16, 2007 |
| 7160869 |
Biologically active metal-containing nucleic acids |
Jan. 9, 2007 |
| 7160721 |
Composition and method for increasing cell density in cell cultures infected with lentivirus |
Jan. 9, 2007 |
| 7160716 |
Device for inducing an immune response in cancer therapy |
Jan. 9, 2007 |
| 7160548 |
Mycobacterium strains with modified erp gene and vaccine composition containing same |
Jan. 9, 2007 |
| 7160547 |
Streptococcal streptolysin S vaccines |
Jan. 9, 2007 |
| 7160545 |
HLA-A24 binding peptides of enhancer of zeste homolog 2 |
Jan. 9, 2007 |
| 7160544 |
Method of vaccinating vertebrates |
Jan. 9, 2007 |
| 7157245 |
Neisserial vaccine compositions and methods |
Jan. 2, 2007 |
| 7157091 |
MAGE-A1 peptides presented by HLA class II molecules |
Jan. 2, 2007 |
| 7157089 |
Immune responses using compositions containing stress proteins |
Jan. 2, 2007 |
| 7157084 |
Extracellular serine protease |
Jan. 2, 2007 |
| 7150875 |
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine |
Dec. 19, 2006 |
| 7150873 |
Coccidiosis vaccines |
Dec. 19, 2006 |
| 7147858 |
Methods to improve immunogenicity of antigens and specificity of antibodies |
Dec. 12, 2006 |
| 7147857 |
Methods for treating high somatic cell counts |
Dec. 12, 2006 |
| 7147854 |
Topical treatment of psoriasis using neutralizing antibodies to interleukin-8 |
Dec. 12, 2006 |
| 7144581 |
Compositions and methods for WT1 specific immunotherapy |
Dec. 5, 2006 |
| 7144580 |
M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
Dec. 5, 2006 |
| 7141363 |
Purposeful movement of human migratory cells away from an agent source |
Nov. 28, 2006 |
| 7141244 |
Helicobacter pylori proteins useful for vaccines and diagnostics |
Nov. 28, 2006 |
| 7138494 |
Sodium-independent small neutral amino acid transporter transporting L- and D-amino acids |
Nov. 21, 2006 |
| 7138125 |
Methods for treating an animal for low milk production |
Nov. 21, 2006 |
| 7138124 |
Polypeptides obtained from gram negative microbes |
Nov. 21, 2006 |
| 7138121 |
Biosensors utilizing dendrimer-immobilized ligands and there use thereof |
Nov. 21, 2006 |
| 7135549 |
Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
Nov. 14, 2006 |
| 7135282 |
Viral particles with exogenous internal epitopes |
Nov. 14, 2006 |
| 7135280 |
Assay to determine efficacy of treatment for mycobacterial infection |
Nov. 14, 2006 |
| 7135278 |
Method of screening for therapeutics for infectious diseases |
Nov. 14, 2006 |
| 7135188 |
Methods and compositions for immunotherapy of cancer |
Nov. 14, 2006 |
| 7135182 |
Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
Nov. 14, 2006 |
| 7135180 |
Preservation of bioactive materials by freeze dried foam |
Nov. 14, 2006 |
| 7135175 |
Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
Nov. 14, 2006 |
| 7132232 |
Identification of viral agents in breast ducts and antiviral therapy therefore |
Nov. 7, 2006 |
| 7132109 |
Using heat shock proteins to increase immune response |
Nov. 7, 2006 |
| 7132107 |
Streptococcus pneumoniae proteins and vaccines |
Nov. 7, 2006 |
| 7132104 |
Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders |
Nov. 7, 2006 |
| 7132102 |
Bacteriocins and novel bacterial strains |
Nov. 7, 2006 |
| 7132101 |
Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
Nov. 7, 2006 |
| 7132099 |
Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide |
Nov. 7, 2006 |
| 7128918 |
Streptococcus antigens |
Oct. 31, 2006 |
| 7128912 |
Fibronectin binding protein compositions and methods of use |
Oct. 31, 2006 |
| 7128910 |
Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof |
Oct. 31, 2006 |
| 7128909 |
Immunstimulating lipid formulation |
Oct. 31, 2006 |
| 7128905 |
Method of treating graft versus host disease by administration of a Fas antagonist |
Oct. 31, 2006 |
| 7125836 |
Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
Oct. 24, 2006 |
| 7125696 |
Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
Oct. 24, 2006 |
| 7125553 |
Methods of inducing immune tolerance using immunotoxins |
Oct. 24, 2006 |
| 7125542 |
Methods and compositions for treating conditions of the eye |
Oct. 24, 2006 |
| 7122370 |
Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
Oct. 17, 2006 |
|
|
|
